Anuh Pharma announced that Bipin N. Shah, Managing Director, relinquished the position of Managing Director of the Company with effect from the closing of business hours of 7 January 2021 for the purpose of Board Restructuring. However, he has been appointed as Non-Executive Director and Vice Chairman of the Company w.e.f. 8 January 2021.

Powered by Capital Market - Live News

The Board of Anuh Pharma at its meeting held on 08 January 2021 has approved the following agenda:

1. Appointment of Bipin N. Shah (DIN: 00083244) as a Non-Executive Director and Vice Chairman of the Company with effect from 08 January 2021;

2. The relinquishment of position of Managing Director by Bipin N. Shah(DIN: 00083244) for the purpose of Board I~estructuring;

3. The appointment and re-designation of Ritesh B. Shah and Vivek B. Shah asJoint Managing Directors from the position of Whole Time Directors & Chief ExecutiveOfficers for a period of 5 years w.e.f. 8 January 2021 to 7 January 2026, they shallnot be liable to retire by rotation, subject to the approval of the· shareholders at theupcoming Annual General Meeting.

Powered by Capital Market - Live News

Net profit of Anuh Pharma rose 120.60% to Rs 6.64 crore in the quarter ended September 2020 as against Rs 3.01 crore during the previous quarter ended September 2019. Sales rose 51.37% to Rs 112.24 crore in the quarter ended September 2020 as against Rs 74.15 crore during the previous quarter ended September 2019.

Powered by Capital Market - Live News

The Board of Anuh Pharma at its meeting held on 06 November 2020 has approved the proposal for listing of Equity Shares of the Company on National Stock Exchange of India (NSE) subject to meeting of the criteria of NSE Listing.

Powered by Capital Market - Live News